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THE serum glycoproteins show a marked increase in cancer, both in man and
in animals (Winzler, 1953; Tombs, James and Maclagan, 1961; Darcy, 1960).
On the other hand there is little information on their levels in tumours or indeed
any othertissues. Extensive studies, using mainly electrophoresis have been made
on rat livers and tumours induced by amino-azo dyes (Sorof, Young and Ott,
1958; Miller and Miller, 1947; Sorof, Cohen, Miller and Miller, 1951). Earlier
work on liver proteins has been summarised by Luck (1949). These were mainly
directed to characterising the basicproteinsinliverwhichbindazo-dyes, andwhich
are absent from the tumour. More recently chromatography on substituted
cellulose has been applied to the same problem (Whitcutt, Sutton and Nunn,
1960 ; Seal and Gutmann, 1961). Glomset (1957) and Moore and Lee (1960) have
also successfully applied substituted cellulose chromatography (Peterson and
Sober, 1956) to the fractionation of proteins and enzymatic activities in rat liver.
Chromatography on substituted cellulose appears to be a suitable method for
the investigation of tumour proteins.
A glycoprotein has recently been isolated from granulation tissue in the rat
(Fishkin and Berenson, 1961); otherwise only indirect evidence of the presence
ofsuch proteins in thetissues isavailable. Forexample, sialic aciddeterminations
suggest the presence of more glycoprotein in tumours than in normal tissues
(Barker, Stacey, Tupper and Kirkmann, 1959). Isotope studies indicate that the
liver is the main source of the serum a globulins (Hochwald, Thorbecke and Asof-
sky, 1961) though the spleen also contributes to their synthesis (Espinosa, 1959).
Both these tissues would be expected, therefore, to contain these components
though this has not been demonstrated.
Darcy (1960) using an immunological method, did not find particularly high
levels of a glycoprotein in certain rat tumours and found a lower level in ascitic
fluid than in serum, but Biserte, Havez, Guerrin, Laturaze and Hayem (1961)
found high levels of ax1 globulins in cancerous ascitic fluids as compared with non-
cancerous ascitic fluids. They also reportthat the 3 5 S glycoprotein was present
in extracts of tumours.
It is not known at present whether the raised serum glycoproteins seen in
cancer are produced by the tumours themselves orwhether the tumours cause some
other tissue to release them. We have tried to obtain evidence on this point by
investigating the proteins of human tumours and those of other human tissues.
METHODS AND MATERIALS
Tissue extractions
Human tissues were obtained at post-mortem or occasionally as operation
specimens. Where possible they were perfused with NaCl solution (0 9 per centHUMAN TISSUES AND TUMOUR PROTEINS
w/v); if this was not possible they were washed in saline to remove as much
blood as possible. They were then homogenised, or stored at 20° until needed.
Thawing and refreezing was avoided. The tissues were roughly minced with scis-
sors and blended in an MSE Atomix with avolume ofbuffer equal to the wet weight
of the tissue (of 0-02 M Na2 HP04pH 8.3). The final buffer composition was thus
near that of the dialysis buffer required for chromatography. Larger volumes
of extractant were not used because it was felt desirable to keep the protein
concentration of the extracts as high as possible (near 4 per cent protein). The
homogenate was then centrifuged at 33,000 g for 20 minutes. Three layers usually
formed; a floating fat layer, a clear layer which was removed by Pasteur pipette,
and solid residue. The fat and solid layers were discarded and the clear layer
treated further.
Temperature during extraction was kept near 4°. All extracts were subse-
quently dialysed for at least 24 hours against the appropriate buffer for chromato-
graphy at the same temperature. It was possible to chromatograph without this
dialvsis, but the large amount of diffusible pigments present made analysis of the
effluent more difficult.
Protein determinations
Protein concentration in the dialysed extract was determined from the re-
fractive index of dialysate and diffusate. In order to determine the appropriate
specific refractive increment ten representative extracts were exhaustively dia-
lysed against phosphate 0 01 m pH 8-3 and the total protein + nucleic acid deter-
mined by drying to constant weight at 1050. Correction was made for the phos-
phate content of the buffer. The mean specific refractive increment was found
to be 1-85 x 10-3 (S.D. 0 29 x 10-3).
Protein concentrations in the effluent after chromatography were determined
either from the absorption at 210 m,u (Tombs, Souter and Maclagan, 1959) or by
the Folin-biuret method (Lowry, Roseborough, Farr and Randall, 1951). The
two methods gave similar results but the latter was preferred since there was no
interference from ribonucleic acid. In the former method 0.1 ml. of effluent was
diluted to 5 ml. with water and the absorption determined at 210 m,u using a
Uvispek spectrophotometer with synthetic silica prism. A specific absorption
of 200 was assumed. For the Folin-biuret method, 0.1 ml. of effluent was added
to 2 ml. of copper sulphate-hydroxide reagent, followed by 0-1 ml. of Folin-
Ciocalteau reagent. Colour developed was measured after 30 minutes at 500 m,u
in 0 5 cm. cuvettes. Crystalline bovine albumin used for a standard calibration
curve and the total extract proteins both gave the same extinction on a dry
weight basis (100 ,ug./0.1 ml. sample 04155 at 500 m,u). The relationship
between protein concentration and colour was not linear, and high phosphate
concentrations (e.g. in the column effluent) depressed the colour at high protein
levels (10 per cent at 250 ,ug./0.1 ml. sample) ; however, calculation showed tbat
variation of phosphate and saline concentration in the effluent would have a
negligible effect on colour development.
C'olumn chromatographic methods
These were developments of the methods described by Tombs, Cooke, Burston
and Maclagan (1961) for serum proteins. Diethylaminoethyl (DEAE) cellulose
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and carboxymethyl (CM) cellulose were prepared as previously described (Tombs
et al., 1961), and the apparatus and general methods were also similar.
A three flask gradient system was used. A spherical flask (500 ml. nominal
capacity) fed into the column and contained 0-01 M sodium phosphate pH 8-3;
this was connected bysiphon to a conical flask (750ml.) containing 0 3 Mphospbate
pH 4*3 which, initsturn, was connected via a siphon to another conical flask (1 1.)
containing 03 M phosphate, 1 M NaCl pH 4-0. This arrangement produced a
smooth concave gradient which finished with an exceptionally powerful eluent.
This was found to be necessary for the removal ofnucleic acids. Under a pressure
of 3 lb. sq. in. the flow rates were about 150 ml./hour for a column diameter of
2 cm.: 6 ml. fractions were collected.
500 mg. of extract protein were usually applied to a column ofDEAE-cellulose
2 X 8 cm. (24 ml. volume) when the run was to be at room temperature. At 40
the capacity of the DEAE cellulose was lower and a column 2 x 14 cm. (44 ml.
volume) was necessary to give the same results. In a large scale experiment 5 g.
of extract protein was run on a column 5 x 16 cm. (212 ml. volume) at room
temperature using the same gradient; equivalent fractionation was obtained.
The absorption of the effluent at 275-280 m,u was determined in an automatic
scanner. The absorption at this wavelength was not accurate for the estimation
of the protein fractions because of interference by pigments, but it was used to
locate fractions and for the determination of nucleic acids. Recovery was 91
per cent (mean of 11), range 75-113 per cent, which is of the same order as that
reported by Moore and Lee (1960).
Carbohydrate determinations
(a) On column effluents.-The cysteine-sulphuric acid method of Dische (1955)
with some modification, was found satisfactory for hexose and ribose in the 5-100
,ug. range. 1 ml. samples of effluent were mixed with 4 ml. concentrated H2S04
and immediately heated at 800 for 10 minutes in a stoppered tube. (Colour de-
velopment solely by means ofthe mixing heat gave erratic results.) After cooling
and standing for 50 minutes at room temperature 0.1 ml. of freshly prepared
3 per cent (w/v) DL-cysteine hydrochloride solution was added with vigorous
mixing.
With hexose (25 ,ug. galactose 25 ,ug. mannose/ml. w/v) a yellow colour ap-
peared almost at once and remained stable for 50 minutes. The absorption curve
showed a broad peak with a maximum at 404 m,t. Ribose (50jig./ml. w/v) gave
no colour but developed absorption with a maximum at 393 min/, reaching stability
after 40 minutes. The hexose and ribose curves had an isosbestic point at 411
m,t. Beer's law was obeyed up to 100 jug. with both hexose and ribose, 100 ,tg.
hexose giving El"em' = 1-24 and 100 utg. of ribose E' m' = 2-16. Both had an
extinction of 1 16 at 411 m,t. 100,ug. offucose gave an E4m ofonly 0-112 and in
the levels normally found in glycoproteins is not likely to interfere; 100 ,g. of
glucosehadan extinction ofE' cu" of 2 3 and anyglycogen present would interfere.
When both hexose and ribose were present an attempt was made to estimate
both from the ratio of absorptions at 404 m,u and 411 m,. For hexose this ratio
had a value of 1-06 while for ribose it was 1-86. The value of the ratio varied
linearly between these values for known mixtures ofribose and hexose.
When measuring on effluent samples it was necessary to include internal blanks
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(without cysteine) to allow for the considerable amounts of pigment present.
The variation in phosphate and saline encountered in the effluent had no effect
on colour development.
(b) On concentrated fractions.-Hexose and hexoseamine were determined by
the methods described by Winzler (1955) using mannose-galactose and glucosa-
mine standards. Uronic acids were tested for by the carbazole method of Dische
(1955).
Electrophoresis
Electrophoresis in agar, and immuno-electrophoresis were carried out as pre-
viously described (Tombs et al., 1961). Effluent was concentrated for electro-
phoresis by pressure filtration through Visking dialysis tubing, or by lyophilisation
after dialysis into water.
Anti-sera
These were prepared in rabbits by injection of 10 mg. of antigen protein
mixed with 5 ml. ofFreunds incomplete adjuvant and 5 ml. 1 per cent aluminium
phosphate suspensions. The mixture was homogenised briefly and then 5 ml.
injected intra-peritoneally and the remainder at various intramuscular sites.
The animal was usually bled after 4 weeks and a booster dose of 2 ml. ofthe above
mixture given after 6 weeks.
Antisera were adsorbed with serum to which a little haemolysed whole blood
had been added. This was necessary to remove antibodies to haemoglobin and
other components of the particulate elements of the blood present in the tissues
as contaminants. The anti-human serum was a horse anti-serum obtained from
the Institut Pasteur, Paris.
RESULTS
Contamination with blood and interstitialfluid
Although all the tissues were washed with saline there was inevitably some
contamination with blood which could be assessedfrom the area ofpeak B (below)
which consists mainly ofhaemoglobin. Since whole blood contains approximately
14 g./100 ml. haemoglobin and 7 g./100 ml. serum protein the total contamination
by serum protein was probably less than one half of the haemoglobin level in
any extract, and this was usually unimportant (5 per cent) in relation to the total
protein of the extract.
A low level of contaimination was confirmed by the absence of y globulin in
peak A (see below). In most cases no y globulin could be detected in this fraction
by immuno-electrophoresis using an anti-human serum. Similarly, 30 per cent
saturation with ammonium sulphate, which precipitates y globulin did not
precipitate the tissue protein in peak A. Proteins originating in serum cannot,
therefore, account for more than a small part of any of the fractions isolated.
It was more difficult to assess the contributions inade by protein in the extra-
cellular space. The extra-cellular volume varies with the tissue but is said to
have a value of 10-24 per cent of the tissue volume for liver (Truax, 1939;
Hawkins, 1960). The extra-cellular fluid is presumably a filtrate of serum with
albumin as the major constituent. Some of the albumin in our extracts may,
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therefore, derive from the spaces between the cells rather than inside them.
100 ml. of liver extract contained approximately 4g. of protein, of which about
1 g. was albumin. Recent direct measurements on muscle interfibre indicated
a variable protein composition but an albumin level 42 per centofthatofthe serum
(Creese, D'Silva and Shaw, 1962). Clearly the interstitial fluid could be the source















FIG. 1.-DEAE-cellulose chromatography ofliver extract protein. 1. Peri-tumour liver, at 18°,
column volume 24ml. 2. The same but at 4°. 3 and 4. The same extract at 4° but column
volume 44 ml. Full line, protein: broken line, pH, 0 hexose and 0, nucleic acid.
In 3 and 4, the figures are the percentage oftotal eluted protein in the indicated fraction;
the two runs are duplicates, to illustrate reproducibility.
Chromatographicfractionation
The chromatography experiments illustrated in Fig. 1 show the good repro-
ducibility ofthe method, and the effect of temperature on the capacity ofDEAE-
cellulose. The capacity is reduced on lowering the temperature (cf. O'Donnel and
Thompson, 1960).
The proportion ofprotein in each fraction was estimated by dividing the peaks
as shown in Fig. 1 into five main regions (A, B, C, D and E).
The absolute amount in each fraction and the proportion are shown in Table I.
Peak B, which was mainly contaminant haemoglobin, has been excluded from
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3a47 g. (100) . 1.72g. (100) . 0 57 g. (97)
I = g. of fraction in 100 g. wet tissue (mean of number indicated)
II = fraction as per cent of total extract protein (mean of number indicated)
:pH
FRACTION NUMBER.
FIG. 2.-DEAE-cellulose chromatography. 1. Normal liver extract protein.
liver. 3. Liver secondary tumours. Details as for Fig. 1.
2. Peritumour
all calculations. It will be seen that the extractable protein-decreased in the order
normal liver, peri-tumour liver, liver tumours (secondary). Comparison between
normal liver and peri-tumour liver (illustrated in Fig. 2). shows that in the latter
the components eluting towards the end of the chromatogram are increased,
particularly fraction E. Similar comparison may be drawn between stomach
and stomach tumour. Liver tumours, although containing much less extractable
protein, have a distribution similar to that of peri-tumour liver. The other
tumours (breast and caecum) were rather similar to the stomach, particularly
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One large tumour mass (a liver secondary) was divided into four parts:
The central core, mainly white necrotic material (wet weight 30 g.).
The next concentric layer passing outwards, ofsimilar appearance (wet weight
100 g.).
The next concentric layer, firm tumour tissue (wet weight 90 g.).
The outermost layers of the tumour, and a small amount of associated liver















FIG. 3.-DEAE-cellulose chromatography ofextracts oflayers ofa single large liver secondary
tumour. 1-3. Layers passing from the outer edge (1) to the core. (3) For furtherdetails see
text. Full line, protein, broken line pH, * hexose and 0, nucleic acid.
Fig. 3 shows the chromatograms of three layers, 1, 3 and 4, layer 2 being very
similar to 3. There was a decrease in absolute carbohydrate levels on passing
outwards from the centre of the tumour, although hexose protein ratios did not
vary. The necrotic core contained a prominent hexose peak in the D region.
Properties of the Fractions
A typical set of results of electrophoresis of the eluted protein fraction from
liver and liver metastases are shown in Fig. 4 and 5. All the ti3sues examined
gave qualitatively similar results, although the results given below apply to liver
and liver metastases.
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FIG. 4.-Electrophoresis andimmuno-electrophoresis offractionAfrom atumour. Anti-human
serum shows the presence of serum y globulin, while anti-A, which had been adsorbed with
serum reveals four non-serum components. Serum is included at the top for comparison of
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FIG. 5.-Electrophoresis and immuno-electrophoresis of fraction CQ and C2. Anti-human serum
reveals serum components; at the bottom anti-liver serum reveals four non-serum compo-
nents.
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Electrophoresis of the fractions showed a general similaritv between many of
the serum and tissue proteins with the exception of fraction A.
Frctction A
This group of proteins constituted about 30 per cent of the extracts. Their
electrophoretic mobilities fell within the y globulin range but their appearance
on electrophoresis was quite different. Four or five sharp bands could be seen,
while immuno-electrophoresis using a rabbit anti-serum specific for this fraction
(i.e. raised against aii A fractioni, then adsorbed with serum) also showed at least
four componenits. This demonstrates that the major part of fraction A is not the
same as any component of serum and they must represent components characteris-
tic of tissue. However, an anti-human serum also sometimes revealed the pre-
sence of small amounits of y globulin.
The proteinis of fraction A were not very stable: they frequently precipitated
immediately on elution from the column and also on reducing the pH to 5. Re-
chromatography on CM-cellulose is not, therefore, a good method of further
fractionation. They were completely precipitated between 50 and 66 per cent
saturation with ammonium sulphate. In some livers a large amount of neutral
undiffusable carbohydrate, which appeared to be glycogen, appeared in this peak.
A concentrate of fraction A from a tumour contained 3-7 per cent hexose and
1 9 per cent hexoseamine.
Fraction B
The fraction was red in colour, and electrophoresis and the specific absorption
spectrum revealed only one major component, haemoglobin.
In several normal livers there was partial resolution of a peak on the trailing
edge of the B peak. Examination of this fraction by immuno-electrophoresis
using anti-human serum indicated a component ofI1 mobility staining with ben-
zidine. This component was in a position similar to the haem-binding /?1B Of
serum, but the intensity of staining suggested that it was not merely a blood
contaminant but was present in the liver. lulB globulin is a glycoprotein and this
would account for at least part of the galactose, mannose and fucose found on
paper chromatography after hydrolysis of this fraction.
Fraction C
This fraction was quantitatively the largest in most cases. The major com-
ponent (C2) had an electrophoretic mobility identical with that of serum albumin,
while immunoelectophoresis showed a strong albumin arc (Fig. 5). This may
have been due to contaminating albumin of serum origin, but it seems likelv that
component C2 is albumin of tissue origin. It usually carried yellow pigments.
In livers, but much less so in tumours, the leading edge of the C peak was re-
solved from the remainder (e.g. Fig. 2). This component, C1, amounted to about
one third of the total peak, and hadthe mobilitvof an a2 globulin (Fig. 5); electro-
phoresis and chromatographic results indicate that there is less of it in tumours
than in liver. The carbohydrate curves (Fig. 3) indicate a compound rich in
hexose eluted in C2 position, and it appears to contain nearly all the carbohydrate
in fraction C. C2, the albumin portion, contained very little carbohydrate. A
concentrate of a large scale preparation of C1 + C2 contained approximately 2-5
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per cent hexose and 1P6 per cent hexoseamine. As the immuno-electrophoresis
results in Fig. 4 and 5 show, both tissues and serum a and/l globulins were present.
Fraction D
As is shown by the chromatograms in Fig. 2 and 3 a carbohydrate rich com-
ponent is eluted on the trailing edge of peak C. The protein fraction (which was
selected as far as possible to coincide with the hexose peak), contained on electro-
phoresis a major component with a mobility very similar to that of serum a,
globulin. Immuno-electrophoresis revealed traces of albumin, and faint lines
corresponding to serum a, globulins, which are not strongly antigenic. The only
sugars which could be detected were galactose, mannose and fucose. Serum
contaminant proteins amount to less than 5 per cent ofpeak D and it is likely that
fraction D corresponds to serum glycoproteins of tissue origin.
On adjusting the whole extract to pH 3-4 precipitation occurred. The pre-
cipitate partially redissolved on raising the pH, and on electrophoresis the main
protein component had an ac globulin mobility. Tumour extracts reached a
maximum of precipitation about one pH unit lower than non-tumour extracts.
Fraction E
This fraction consisted of a number of small peaks eluted under conditions
which indicate the presence of an acidic protein. Electrophoresis gave poorly
staining bands in the sc1 region. Components migrating faster than albumin
were also present, but the fraction reacted with neither anti-liver nor anti-
serum anti-serum. The fraction is rich in carbohydrate. A typical E fraction
from a tumour contained 10 per cent hexose and 855 per cent hexoseamine. No
uronic acid could be found.
RNA and Fraction F
The final peak consisted mainly of RNA, with a small and variable amount of
associated protein (F). The absorption curve was typical of nucleic acids, and
ribose was the only sugar detected in a hydrolysate.
DISCUSSION
The cytoplasmic proteins must exist in an intimate relationship with the plasma
proteins. Albumin in particular has been recognised as a constituent of both
plasma and cytoplasm (Gordon and Humphrey, 1961), while all the plasma
proteins must ultimately have their origin in the tissues. Any attempt to make
a clear distinction between soluble cytoplasmic proteins and plasma proteins must,
therefore, be difficult, and is further complicated in our experiments by the
presence of traces of contaminant serum and the problematical contribution of
the interstitial fluid. Although an antihuman serum will detect constituents of
serum it will not distinguish between those originating in the cells and those
from serum itself. On the other hand, the anti-liver antiserum used in this work
should react only with tissue proteins different from serum proteins, and in this
way it was possible to show that a major part of the cytoplasmic protein is
completely absent from the plasma.
Approximately 70 per cent of the extracted protein was similar to serum
components. These proteins were found mainly in fractions C and D and were
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principally albumin and a, and a2 globulins. The a,1 globulin is of special interest
because ofitspossible relationship to the serum a, globulin with which it appeared
to be identical. This protein was detected inliver, kidney, spleen, breast, stomach
small intestine and various tumours. The °C2 globulin fraction contained some
serum components and some confined to the tissues. The remaining 30 per cent
were exclusively tissue components and consisted mainly of basic proteins in
fraction A. The mechanism by which these are selectively retained in the cell
is obscure.
Comparison of tumours with other non-tumour tissue, even their tissue of
origin, is hazardous since organs frequently contain several different types of cell
which cannot be examined separately by present methods, but which may each
give rise to different types oftumour. Some general points may be made however.
Tumours, and all the tissues examined, had a similar qualitative protein com-
position. There was no obvious component either present in or absent from
tumours as compared with non-tumour tissue, though our examination was not
detailed enough to exclude a minor protein deletion of the type described by
Miller and Miller (1947) in azo-dye carcinogenesis. Liver metastases tended to
be similar to each other, though breast and stomach tumours had a rather different
distribution, with a much lower A fraction. Stomach tumour contained a high
proportion of peak E. A more valid comparison may be made between normal
and peri-tumour liver: here the most striking difference is an increase in E and a
decrease in A. The peri-tumour liver contained less extractable protein, but even
so the level of E is higher than in normal liver. The balance is clearly moved
to more acidic components, and this is presumably a response to the presence of
tumours. The tumours themselves actually contain a lower proportion of E and
a slightly higher proportion of fraction D than does the cancerous liver.
The liver is the normal source ofa, globulins, and the changes in peri-tumour
liver suggest the possibility that the tumours were inducing the liver to increase
its production; certainly in such cases the level in the liver increased. The
presence of a relatively high proportion of D in necrotic parts of a tumour as
compared with the viable segments suggests the possibility that some of the
circulating glycoproteins might be released from such decaying tissue, but there
is at present no conclusive evidence to show that tumours directly produce them.
In any case tumour production is unlikely to be the source of the general rise in
cancer, since quite small non-necrotic tumours may cause it (Nisselbaum and
Bernfeld, 1956). The results as a whole suggest that in cancer the liver is stimula-
ted to produce excessive amounts of ac, glycoprotein, presumably by a humoral
mechanism.
SUMMARY
1. Soluble cytoplasmic proteins ofhumanliver, kidney, spleen, breast, stomach,
small intestine and various tumours have been separated into five main protein
fractions (A-E) and RNA by chromatography on DEAE-cellulose and have been
examined by immunological and electrophoretic methods.
2. Fraction A comprised some 30 per cent of the extract protein, and was a
complex mixture of basic proteins which were shown to be absent from serum.
3. Fraction B was haemoglobin: C contained mainly albumin, but a globulins,
some of which were absent from serum, were also detected.
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4. Fractions D and E contained a1 globulins with properties very similar to
those of serum ot, globulins.
5. In peri-tumour liver, as compared with non-cancerous liver, D and E were
increased and A decreased. Tumours themselves however, were not particularly
rich in the acidic proteins.
6. It is concluded that the increase in circulating glycoprotein in cancer is at
least partly due to increased production by the liver.
We are much indebted to Professor A. D. Morgan and his colleagues for pro-
viding specimens. The work was supported by generous grants from the British
Empire Cancer Campaign and from the Endowment Funds of Westminster
Hospital.
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